|
DUSP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.617100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.163200E-03 |
| Normal-vs-Stage2 |
5.005600E-01 |
| Normal-vs-Stage3 |
4.020400E-03 |
| Normal-vs-Stage4 |
1.624800E-03 |
| Stage1-vs-Stage2 |
8.903500E-02 |
| Stage1-vs-Stage3 |
6.799000E-01 |
| Stage1-vs-Stage4 |
2.005400E-01 |
| Stage2-vs-Stage3 |
4.777500E-02 |
| Stage2-vs-Stage4 |
1.533640E-02 |
| Stage3-vs-Stage4 |
3.250200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.419120E-03 |
| Normal-vs-AfricanAmerican |
1.436640E-01 |
| Normal-vs-Asian |
5.500000E-02 |
| Caucasian-vs-AfricanAmerican |
7.032600E-01 |
| Caucasian-vs-Asian |
6.852200E-01 |
| AfricanAmerican-vs-Asian |
9.534600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.964100E-04 |
| Normal-vs-Female |
1.919550E-02 |
| Male-vs-Female |
3.791700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.096400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.535330E-03 |
| Normal-vs-Age(61-80Yrs) |
9.918600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.866400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.525840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.616800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.088000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.914400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.872400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.780400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.811800E-01 |
| Classical-VS-Follicular |
5.455400E-01 |
| Classical-VS-Other |
2.791600E-02 |
| Classical-VS-Normal |
6.558900E-03 |
| Tall-VS-Follicular |
3.363400E-01 |
| Tall-VS-Other |
3.221900E-02 |
| Tall-VS-Normal |
2.137700E-02 |
| Follicular-VS-Other |
5.588200E-02 |
| Follicular-VS-Normal |
1.186350E-01 |
| Other-VS-Normal |
3.023100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.198000E-03 |
| Normal-vs-N1 |
1.627940E-02 |
| N0-vs-N1 |
9.075600E-01 |
|
|
